We are live on ! Find out more
BC

Broadfin Capital Portfolio holdings

AUM $747M
1-Year Est. Return 100.56%
This Fund
S&P 500
This Quarter Est. Return
-21.9%
1 Year Est. Return
+100.56%
3 Year Est. Return
+297.65%
5 Year Est. Return
+365.91%
10 Year Est. Return
–
AUM
$1.8B
AUM Growth
-$63.5M
Cap. Flow
+$448M
Cap. Flow %
24.92%
Top 10 Hldgs %
55.9%
Holding
105
New
11
Increased
30
Reduced
27
Closed
15

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$58.4M
2
NVRO
NEVRO CORP.
NVRO
+$57.5M
3
CSII
Cardiovascular Systems, Inc.
CSII
+$30.2M
4
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
+$18.2M
5
MASI
Masimo
MASI
+$17.2M

Top Sells

Rank Stock Value
1
ASRT
Assertio
ASRT
+$25.1M
2
ALR
Alere Inc
ALR
+$23.9M
3
HRTX icon
Heron Therapeutics
HRTX
+$17.8M
4
AVDL
Avadel Pharmaceuticals
AVDL
+$12.8M
5
AEGR
Aegerion Pharmaceuticals
AEGR
+$9.48M

Sector Composition

Rank Sector Weight
1 Healthcare 63.28%
2 Technology 0.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEAR
101
DELISTED
TearLab Corporation
TEAR
– –
-91,450
Closed -$1.85M
UNIS
102
DELISTED
Unilife Corporation
UNIS
– –
-115,000
Closed -$2.47M
TRIV
103
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
– –
-6,032
Closed -$32K
TRNX
104
DELISTED
TORNIER N V SHARES (NLD)
TRNX
– –
-100,000
Closed -$2.5M
1 2 3 4
5

Similar funds

CBU
CIBC Bank USA Chicago, Illinois $756M AUM 24.68% 1-Year Est. Return
CONA
Capital One National Association New York $756M AUM
MP
Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return
SC
Selz Capital New York $570M AUM 35.56% 1-Year Est. Return
KGACF
Kopernik Global All-Cap Fund Tampa, Florida $558M AUM
BPWA
Beacon Pointe Wealth Advisors Newport Beach, California $543M AUM 23.61% 1-Year Est. Return
TRAM
Tuscan Ridge Asset Management Chicago, Illinois $984M AUM 25.8% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Broadfin Capital's Q3 2015 Portfolio in Review

As of Q3 2015, Broadfin Capital held 105 positions worth $1.8B, down 3.4% from $1.86B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Broadfin Capital deployed $448M of net new capital in Q3 2015, opening 11 new positions and adding to 30 existing holdings. Its largest new stake was Cardiovascular Systems, Inc.: 1,200,000 shares worth $19M.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, down from 76% a quarter earlier, followed by Technology.

On the sell side, the largest reduction was Heron Therapeutics, an estimated $17.8M trimmed.

  • Broadfin Capital's largest Q3 2015 buy was Cardiovascular Systems, Inc.: 1,200,000 shares worth $19M.
  • Broadfin Capital added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015, an estimated $58.4M increase.
  • Broadfin Capital's biggest Q3 2015 reduction was Heron Therapeutics, cutting an estimated $17.8M.
  • Broadfin Capital fully exited Assertio in Q3 2015, selling an estimated $25.1M.
  • Broadfin Capital's ten largest holdings make up 56% of its $1.8B portfolio in Q3 2015.
  • Broadfin Capital opened 11 new positions and closed 15 in Q3 2015.
  • Broadfin Capital's portfolio value fell 3.4% quarter-over-quarter to $1.8B.

Based on Broadfin Capital's 13F filing for Q3 2015, filed 16 Nov 2015.